Dr Ira Daly, Executive Vice President
Dr. Daly stands as a distinguished professional with an impressive track record, boasting over 35 years of extensive experience dedicated to supporting the regulatory and preclinical toxicology needs of the pharmaceutical and medical device industries. His comprehensive expertise is underlined by dual certifications, as he is Board Certified in toxicology and regulatory affairs by both the American Board of Toxicology and the Regulatory Affairs Professional Society. Furthermore, his stature in the field is marked by his fellowship with the Society of Biology in London.
In his role as a consultant, Dr. Daly has been a driving force in various realms of drug and medical device development. His involvement spans a diverse array of therapeutic areas, encompassing epigenetic enzyme inhibitors, anti-neoplastics, antibiotics, anti-inflammatories, anti-convulsants, V2 and V1a receptor antagonists, 5HT agonists, antisense oligonucleotides, PTH related compounds, contraceptives, hemostatic agents, and a myriad of medical devices. Notably, Dr. Daly is not only engaged in the scientific aspects but has also been instrumental in program development, management, and regulatory submission preparation (IND, NDA, CTD, 510(k), etc.). His adeptness extends to risk assessment, regulatory interface, and due diligence efforts.
Dr. Daly's contributions are not confined solely to pharmaceuticals and medical devices; he actively extends his consultancy to clients in the cosmetic, food, and chemical industries. This versatility speaks to his broad knowledge base and adaptability across diverse sectors.
His service on a new animal drugs for minor use and minor species expert panel for the FDA underscores his commitment to advancing regulatory standards and ensuring the safety and efficacy of emerging pharmaceuticals. Dr. Daly's multi-faceted expertise positions him as a sought-after professional in areas such as drug and medical device preclinical development, risk assessment, regulatory affairs, as well as safety considerations in the cosmetic, food, and chemical sectors.
In summary, Dr. Daly's remarkable career is defined by his dedication to advancing scientific and regulatory standards, encompassing a wide range of therapeutic areas and industries. His dual certifications, fellowship, and diverse project involvements showcase a seasoned professional with an unwavering commitment to excellence and innovation.